Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus – International Task Force

For decades, sulfonylureas (SUs) have been important drugs in the antidiabetic therapeutic armamentarium. They have been used as monotherapy as well as combination therapy. Focus on newer drugs and concerns about the risk of severe hypoglycemia and weight gain with some SUs have led to discussion on...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Indian J Endocrinol Metab
Autori principali: Kalra, Sanjay, Bahendeka, Silver, Sahay, Rakesh, Ghosh, Sujoy, Md, Fariduddin, Orabi, Abbas, Ramaiya, Kaushik, Al Shammari, Sameer, Shrestha, Dina, Shaikh, Khalid, Abhayaratna, Sachitha, Shrestha, Pradeep K., Mahalingam, Aravinthan, Askheta, Mazen, A. Rahim, Aly Ahmed, Eliana, Fatimah, Shrestha, Hari K., Chaudhary, Sandeep, Ngugi, Nancy, Mbanya, Jean Claude, Aye, Than Than, Latt, Tint Swe, Akanov, Zhanay A., Syed, Abbas Raza, Tandon, Nikhil, Unnikrishnan, A. G., Madhu, S. V., Jawa, Ali, Chowdhury, Subhankar, Bajaj, Sarita, Das, Ashok Kumar
Natura: Artigo
Lingua:Inglês
Pubblicazione: Medknow Publications & Media Pvt Ltd 2018
Soggetti:
Review Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5838894/
https://ncbi.nlm.nih.gov/pubmed/29535952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijem.IJEM_556_17
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi